Victoria currently is driving new areas of paediatric acute leukaemia research, teamed with Dr Pam Kearns, Director of Birmingham Cancer Research Clinical Trials Unit (CRCTU).
Specifically, she is interested in molecular mechanisms underlying chemo-resistance and relapse in acute myeloid leukaemia and acute lymphoblastic leukaemia, with the goal of informing and testing ...